Immediate Impact
50 standout
Citing Papers
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
Targeted protein degradation: advances in drug discovery and clinical practice
2024 Standout
Works of Alan Van Goethem being referenced
Dual targeting of MDM2 and BCL2 as a therapeutic strategy in neuroblastoma
2017
Pharmacologic activation of wild-type p53 by nutlin therapy in childhood cancer
2013
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Alan Van Goethem | 133 | 31 | 100 | 39 | 8 | 174 | |
| M. Di Katie Sebastiano | 79 | 15 | 60 | 25 | 9 | 113 | |
| Kirsty M. Ferguson | 118 | 14 | 46 | 23 | 6 | 153 | |
| Sara De Brouwer | 151 | 71 | 77 | 34 | 10 | 197 | |
| Andrés Quintero | 101 | 95 | 77 | 34 | 7 | 220 | |
| Christin Zasada | 103 | 15 | 79 | 23 | 6 | 160 | |
| Zhong Chen | 58 | 8 | 60 | 39 | 8 | 130 | |
| Noan‐Minh Chau | 154 | 13 | 158 | 52 | 7 | 224 | |
| Simranjit X. Singh | 242 | 11 | 105 | 25 | 7 | 283 | |
| Tim van Groningen | 122 | 120 | 76 | 66 | 6 | 200 | |
| Laura Creevey | 176 | 75 | 128 | 31 | 6 | 220 |
All Works
Login with ORCID to disown or claim papers
Loading papers...